Key facts
- This page summarizes Steve E. Krognes's Form 4 filing for Guardant Health, Inc. (GH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Apr 2024, 17:25.
Steve E. Krognes - 31 Mar 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Director
- Issuer ticker
- GH
- Reported as of
- 31 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2024, 17:25:09 UTC
- Prior SEC filing
- 01 Mar 2024
- Next SEC filing
- 02 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Saia, as attorney-in-fact for Steve Krognes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 4 for Guardant Health, Inc. (GH) on 01 Apr 2024.
Change
- Previous filing in this sequence was filed on 01 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +154
- Change %
- +5%
- Price
- $0.000000
- Shares after
- 3,239
- Date
- 31 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -154
- Change %
- -3.6%
- Price
- $0.000000
- Shares after
- 4,166
- Date
- 31 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 154
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This represents a restricted stock unit award granted on August 9, 2022 that vests as to 25% of the shares subject to such award on June 30, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of June 30, 2023, during the three-year period thereafter.
Footnote F2
Not applicable for Restricted Stock Units.